somal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun.
200:710 –715; 1994.
Daniels, W. M.; van Rensburg, S. J.; van Zyl, J. M.; Taljaard,
J. J. Melatonin prevents beta-amyloid-induced lipid peroxidation. J. Pineal Res. 24:78–82; 1998.
Gridley, K. E.; Green, P. S.; Simpkins, J. W. Low concentrations
of estradiol reduce beta-amyloid (25–35)-induced toxicity, lipid
peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778:158 –165; 1997.
Bruce-Keller, A. J.; Begley, J. G.; Fu, W.; Butterfield, D. A.;
Bredesen, D. E.; Hutchins, J. B.; Hensley, K.; Mattson, M. P.
Bcl-2 protects isolated plasma and mitochondrial membranes
against lipid peroxidation induced by hydrogen peroxide and
amyloid beta-peptide. J. Neurochem. 70:31–39; 1998.
Mark, R. J.; Fuson, K. S.; May, P. C. Characterization of
8-epiprostaglandin F2 as a marker of amyloid -peptide-in-duced oxidative damage. J. Neurochem. 72:1146 –1153; 1999.
Mark, R. J.; Lovell, M. A.; Markesbery, W. R.; Uchida, K.;
Mattson, M. P. A role for 4-hydroxynonenal, an aldehydic
product of lipid peroxidation, in disruption of ion homeostasis
and neuronal death induced by amyloid -peptide. J. Neurochem. 68:255–264; 1997.
Avdulov, N. A.; Chochina, S. V.; Igbavboa, U.; O'Hare, E. O.;
Schroeder, F.; Cleary, J. P.; Wood, W. G. Amyloid beta-peptides
increase annular and bulk fluidity and induce lipid peroxidation
in brain synaptic plasma membranes. J. Neurochem. 68:2086 –
2091; 1997.
Subramaniam, R.; Roediger, F.; Jordan, B.; Mattson, M. P.;
Keller, J. N.; Waeg, G.; Butterfield, D. A. The lipid peroxidation
product, 4-hydroxy-2-trans-nonenal, alters the conformation of
cortical synaptosomal membrane proteins. J. Neurochem. 69:
1161–1169; 1997.
Pocernich, C. B.; Cardin, A.; Racine, C.; Lauderback, C. M.;
Butterfield, D. A. Glutathione elevation and its protective role in
acrolein-induced protein damage in synaptosomal membranes:
relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem. Int. 39:141–149; 2001.
Lovell, M. A.; Xie, C.; Markesbery, W. R. Acrolein is increased
in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22:187–194; 2001.
Subbarao, K. V.; Richardson, J. S.; Ang, L. C. Autopsy samples
of Alzheimer's cortex show increased peroxidation in vitro.
Neurology 45:1594 –1601; 1990.
Balazs, L.; Leon, M. Evidence of an oxidative challenge in the
Alzheimer's brain. Neurochem. Res. 19:1131–1137; 1994.
Palmer, A. M.; Burns, M. A. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease.
Brain Res. 645:338 –342; 1994.
Lovell, M. A.; Ehmann, W. D.; Butler, S. M.; Markesbery, W. R.
Elevated thiobarbituric acid-reactive substances and antioxidant
enzyme activity in the brain in Alzheimer's disease. Neurology
45:1594 –1601; 1995.
Marcus, D. L.; Thomas, C.; Rodriguez, C.; Simberkoff, K.; Tsai,
T. S.; Strafaci, J. A.; Fremann, M. L. Increased peroxidation and
reduced antioxidant enzyme activity in Alzheimer's disease.
Exp. Neurol. 150:40–44; 1998.
Takaoma, A.; Miyatake, F.; Matsuno, S.; Ishii, K.; Nagase, S.;
Sahara, N.; Ono, S.; Mori, H.; Wakabayashi, K.; Tsuji, S.;
Takahashi, H.; Shoji, S. Apolipoprotein E allele-dependent an-tioxidant activity in brains with Alzheimer's disease. Neurology
54:2319 –2321; 2000.
Lauderback, C. M.; Hackett, J.; Keller, J. N.; Varadarajan, S.;
Szweda, L.; Kindy, M. S.; Butterfield, D. A. Apoliprotein E
knock-out synaptosomes are vulnerable to A (1–40)-induced
oxidative injury. Biochemistry 40:2548 –2554; 2001.
Miatto, O.; Gonzalez, R. G.; Buonanno, F.; Growdon, J. H. In
vitro 31P NMR spectroscopy detects altered phospholipids me-tabolism in Alzheimer's disease. Can. J. Neurol. Sci. 13:535–
539; 1986.
Nitsch, R. M.; Blusztajan, J. K.; Pittas, A. G.; Slak, B. E.;
